Exceptional Results in Neuroendocrine-Metastases-Caused Paraplegia Treated with [90Y-DOTA]-d -Phe1-Tyr3-octreotide (90Y-DOTATOC), a Radiolabelled Somatostatin Analogue

Fuller, 1997, Spinal cord compression, 2476 Prinz, 1981, Clinical aspects of glucagon producing islet cell tumors, Am J Gastroenterol, 76, 125 Oeberg, 1998, Advances in chemotherapy and biotherapy of endocrine tumors, Opin Oncol, 10, 58, 10.1097/00001622-199801000-00010 Faiss, 1996, Drug therapy in metastatic neuro-endocrine tumors of the gastroenteropancreatic system, Recent Results Cancer Res, 142, 193, 10.1007/978-3-642-80035-1_12 Pelley, 1999, Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors, Curr Opin Oncol, 11, 32, 10.1097/00001622-199901000-00008 1999, Eur J Surg Oncol, 25, 3, 10.1053/ejso.1998.0593 Otte, 1998, Yttrium-90 labelled somatostatin-analogue for cancer treatment, Lancet, 351, 417, 10.1016/S0140-6736(05)78355-0 Cremonesi, 1999, Biokinetics and dosimetry in patients administered with 111In -Tyr3-octreotide: implications for internal radiotherapy with 90Y-DOTATOC, Eur J Nucl Med, 26, 877, 10.1007/s002590050462